Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Kesterson

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Annals of Diagnostic Pathology|October 19, 2010
Malignant mixed müllerian tumor of primary peritoneal originMargaux Kanis, Joshua P Kesterson, Stuti Shroff, et al.
Gynecologic Oncology Reports|November 22, 2017
Tumor lysis syndrome in a patient with ovarian yolk sac tumorKatherine VanHise, Alexa Swailes, Michael Roche, et al.
Oncology Reviews|July 10, 2018
The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping reviewMichael Roche, Laura Parisi, Linda Li, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 30, 2016
Evaluation of Association Between Gynecologic Oncology Fellowship Length and a Career in Academic MedicineJoshua P Kesterson, J Brian Szender, Eric Schaefer, et al.
Gynecologic Oncology|November 1, 2011
Expression of the opioid growth factor-opioid growth factor receptor axis in human ovarian cancerJames Fanning, Carrie A Hossler, Joshua P Kesterson, et al.
Journal of Minimally Invasive Gynecology|October 27, 2016
Surgical Competency for Robot-Assisted Hysterectomy: Development and Validation of a Robotic Hysterectomy Assessment Score (RHAS)Peter J Frederick, J Brian Szender, Ahmed A Hussein, et al.
Gynecologic Oncology|December 1, 2015
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group StudyElizabeth R Burton, Mark Brady, Howard D Homesley, et al.
Gynecologic Oncology|October 4, 2016
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyPeter G Rose, James J Java, Mark A Morgan, et al.
Obstetrics and Gynecology|June 8, 2022
In ReplyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Obstetrics and Gynecology|January 6, 2022
Symptoms of Women With High-Risk Early-Stage Ovarian CancerJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Annals of Diagnostic Pathology|October 19, 2010
Malignant mixed müllerian tumor of primary peritoneal originMargaux Kanis, Joshua P Kesterson, Stuti Shroff, et al.
Gynecologic Oncology Reports|November 22, 2017
Tumor lysis syndrome in a patient with ovarian yolk sac tumorKatherine VanHise, Alexa Swailes, Michael Roche, et al.
Oncology Reviews|July 10, 2018
The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping reviewMichael Roche, Laura Parisi, Linda Li, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 30, 2016
Evaluation of Association Between Gynecologic Oncology Fellowship Length and a Career in Academic MedicineJoshua P Kesterson, J Brian Szender, Eric Schaefer, et al.
Gynecologic Oncology|November 1, 2011
Expression of the opioid growth factor-opioid growth factor receptor axis in human ovarian cancerJames Fanning, Carrie A Hossler, Joshua P Kesterson, et al.
Journal of Minimally Invasive Gynecology|October 27, 2016
Surgical Competency for Robot-Assisted Hysterectomy: Development and Validation of a Robotic Hysterectomy Assessment Score (RHAS)Peter J Frederick, J Brian Szender, Ahmed A Hussein, et al.
Gynecologic Oncology|December 1, 2015
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group StudyElizabeth R Burton, Mark Brady, Howard D Homesley, et al.
Gynecologic Oncology|October 4, 2016
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyPeter G Rose, James J Java, Mark A Morgan, et al.
Obstetrics and Gynecology|June 8, 2022
In ReplyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Obstetrics and Gynecology|January 6, 2022
Symptoms of Women With High-Risk Early-Stage Ovarian CancerJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Pageof 3